Comparing Effects of Two Fixed Combinations Ophthalmic Solutions on Ocular Blood Flow
- First Posted Date
- 2008-12-19
- Last Posted Date
- 2019-04-24
- Lead Sponsor
- Allergan
- Target Recruit Count
- 15
- Registration Number
- NCT00811850
Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma
- First Posted Date
- 2008-12-17
- Last Posted Date
- 2013-10-18
- Lead Sponsor
- Allergan
- Target Recruit Count
- 172
- Registration Number
- NCT00809848
Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema
- First Posted Date
- 2008-11-27
- Last Posted Date
- 2019-04-23
- Lead Sponsor
- Allergan
- Target Recruit Count
- 56
- Registration Number
- NCT00799227
Efficacy of Ketorolac 0.4% in Prostaglandin Suppression
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2011-09-23
- Lead Sponsor
- Allergan
- Target Recruit Count
- 9
- Registration Number
- NCT00791323
Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-10-20
- Last Posted Date
- 2012-09-03
- Lead Sponsor
- Allergan
- Target Recruit Count
- 44
- Registration Number
- NCT00775411
Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-09-29
- Last Posted Date
- 2013-11-19
- Lead Sponsor
- Allergan
- Target Recruit Count
- 65
- Registration Number
- NCT00761592
Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-09-29
- Last Posted Date
- 2013-11-19
- Lead Sponsor
- Allergan
- Target Recruit Count
- 50
- Registration Number
- NCT00761202
Efficacy and Acceptability of Two Lubricant Eye Drops
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-09-22
- Last Posted Date
- 2011-10-31
- Lead Sponsor
- Allergan
- Target Recruit Count
- 51
- Registration Number
- NCT00756678
Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-08-15
- Last Posted Date
- 2019-04-23
- Lead Sponsor
- Allergan
- Target Recruit Count
- 204
- Registration Number
- NCT00735449
Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-07-17
- Last Posted Date
- 2012-01-12
- Lead Sponsor
- Allergan
- Target Recruit Count
- 781
- Registration Number
- NCT00717418
Ā© Copyright 2024. All Rights Reserved by MedPath